AzTrials
AzTrials

Analgesia, EpiduralRUPONCT02290054

Auriculotherapy for Prevention of Postoperative Urinary Retention

A study testing Treated and Intra-venous anesthesia in people with Analgesia, Epidural, run by Hopital Foch at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Urinary retention is a common complication of epidural analgesia. Auriculotherapy could prevent this complication. This study will be performed among men receiving thoracic epidural analgesia after thoracic surgery. Read more about this study

Who is it for?
Ages 18 to 85 years, men only
Conditions the study is for
Analgesia, Epidural
What is being tested?
Treated and Intra-venous anesthesia
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
53 participants
Where
1 siteFrance
Study dates
Apr 2014to 23 May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients scheduled to a lung surgical procedure and thoracic epidural analgesia

Who cannot join

  • Abnormalities of the external ear
  • Dialysis or end stage renal failure
  • Abnormal urinary tract
  • Incapacity to self assessment of comfort and anxiety,
  • Contra-indication to total intravenous anesthesia

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Foch

    Suresnes, Hauts de Seine, 92151

Other trials in France

About this study

Official title: Auriculotherapy for Prevention of Postoperative Urinary Retention in Men Receiving Postoperative Epidural Analgesia After Thoracic Surgery

Urinary retention is a common complication of epidural analgesia. Auriculotherapy could prevent this complication. This study will be performed among men receiving thoracic epidural analgesia after thoracic surgery.

Being tested
Control, Treated, Intra-venous anesthesia
Keywords
analgesia, epidural, urinary retention
Medical subject headings
Agnosia, Urinary Retention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ControlProcedure or surgery

    Also called Sham Comparator

    Implementation of adhesive pads on the ears is performed while the patient is sleeping but before thoracic incision.

  • TreatedProcedure or surgery

    Also called Auriculotherapy

    Auriculotherapy uses semi-permanent needles and implementation of adhesive pads to mask the needles.

  • Intra-venous anesthesiaProcedure or surgery

Study groups in NCT02290054
Study groupRoleWhat they receive
ControlSham comparatorA thoracic epidural catheter is inserted first. Then total intra-venous anesthesia is performed. Implementation of adhesive pads on the ears is performed while the patient is sleeping but before thoracic incision.
Receives: Procedure: Control; Procedure: Intra-venous anesthesia
TreatedExperimentalA thoracic epidural catheter is inserted first. Then total intra-venous anesthesia is performed. Auriculotherapy is performed while the patient is sleeping but before thoracic incision. Auriculotherapy uses semi-permanent needles and implementation of adhesive pads to mask the needles.
Receives: Procedure: Treated; Procedure: Intra-venous anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bladder catheterization

    Requirement of bladder catheterization during the day and the first night following surgery

    Measured: 24 hours

Secondary outcomes (2)
  1. Comfort

    The degree of patient's comfort is assessed six hours after his arrival in the recovery room and the morning after surgery using a numerical scale from 0 '"maximum discomfort " to 10" maximum comfort "

    Measured: 24 hours

  2. Anxiety

    The degree of patient's anxiety is assessed six hours after his arrival in the recovery room and the morning after surgery using a numerical scale from 0 '"maximum discomfort " to 10" maximum comfort "

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2014 (estimated)
  2. Study startApr 2014
  3. Primary completion23 May 2016
  4. Study completion23 May 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
53 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02290054
Sponsor's protocol ID
2013/41
Other IDs
2013-A01396-39
Acronym
RUPO
Status last verified
Jun 2017
First submitted
8 Nov 2014
Last updated
8 Jun 2017
Results posted
No
Data monitoring committee
No

Publications

  • Michel-Cherqui M, Szekely B, Lemoyne F, Feliot E, Gayat E, Fischler M. Auriculotherapy in the prevention of postoperative urinary retention in patients with thoracotomy and thoracic epidural analgesia: A randomized, double-blinded trial. Medicine (Baltimore). 2019 Jun;98(23):e15958. doi: 10.1097/MD.0000000000015958.

    PubMed 31169723

Questions about this trial

What is this clinical trial studying?

A study testing Treated and Intra-venous anesthesia in people with Analgesia, Epidural, run by Hopital Foch at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bladder catheterization (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02290054, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in